Enable JavaScript to visit this website.

Anti-Infective Landing Page

Pfizer announces the 2018 ASPIRE Awards Program in Anti-Infectives

Mission

The Advancing Science through Pfizer: Investigator Research Exchange (ASPIRE) program is a competitive grants program that reflects the commitment of Pfizer Anti-Infectives to support ongoing scientific and clinical investigation in the treatment and clinical management of patients with serious infections.

Background

Scientific research continues to advance our knowledge and understanding of the optimal treatment and clinical management of patients with serious infections. Pfizer invites interested investigators in Europe, Latin America, Africa, the Middle East, and Asia Pacific to apply for a 2018 ASPIRE AWARD in Anti-Infectives through submission of innovative research proposals designed to accomplish the mission of advancing knowledge in the treatment and management of serious infections.

Areas of Focus

The primary objective of the program is to improve understanding of the use of ceftaroline fosamil in the treatment of serious infections. Applications comprising laboratory investigation, clinical, or health outcomes research will be considered. Specific areas of interest are as follows:

  • Ceftaroline fosamil for the treatment of severe CAP or cSSTI (e.g., PORT IV or V, ICU, secondary bacteremia, treatment failures, resistant pathogens [including MRSA, penicillin resistant S. pneumoniae, etc.]) in adults and children. Comparative studies will be given priority.
  • Research related to the use of ceftaroline fosamil in the treatment of serious infections with an unmet therapeutic need (e.g., bacterial meningitis, Staphylococcus aureus bacteremia, diabetic foot infection)
  • Real world use of ceftaroline fosamil, including health economic outcomes, comparative clinical data, etc. in adults and children
  • PK/PD of ceftaroline fosamil in adults and children: tissue penetration (including CNS, bone, etc.), target attainment, etc.

Available Awards

The ASPIRE Anti-Infectives research awards are up to a maximum of $100,000 each. Larger grants may be considered depending on scope and merit of proposal. Up to 5 awards may be given.

Selection of research proposals will be performed by an independent, external review committee comprised of established experts in the field. Proposals are reviewed based on areas of focus, scientific merit, originality, and feasibility.

Research projects are expected to complete within 2 years of study start.

Application is open to investigators in Europe, Latin America, Africa, the Middle East and Asia Pacific.

Applications must be received by Friday, May 25, 2018, 11:59 pm Eastern Time